Pivonello, Claudia (2011) Role of mTOR system and its relation with somatostatin and dopamine receptors on cell proliferation, hormone secretion and intracellular signalling in hepatocellular and cholangiocellular carcinomas. [Tesi di dottorato] (Unpublished)

[thumbnail of Claudia_Pivonello_24.pdf]
Preview
PDF
Claudia_Pivonello_24.pdf

Download (2MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: Role of mTOR system and its relation with somatostatin and dopamine receptors on cell proliferation, hormone secretion and intracellular signalling in hepatocellular and cholangiocellular carcinomas.
Creators:
Creators
Email
Pivonello, Claudia
claudia.pivonello@unina.it
Date: 29 November 2011
Number of Pages: 66
Institution: Università degli Studi di Napoli Federico II
Department: Biologia e patologia cellullare e molecolare "L. Califano"
Scuola di dottorato: Medicina molecolare
Dottorato: Patologia e fisiopatologia molecolare
Ciclo di dottorato: 24
Coordinatore del Corso di dottorato:
nome
email
Avvedimento, Vittorio Enrico
UNSPECIFIED
Tutor:
nome
email
Lombardi, Gaetano
UNSPECIFIED
Date: 29 November 2011
Number of Pages: 66
Keywords: HCC, CC, somatostatin receptors, dopamine receptors, mTOR inhibitors
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/13 - Endocrinologia
Date Deposited: 13 Dec 2011 11:31
Last Modified: 05 Dec 2014 11:46
URI: http://www.fedoa.unina.it/id/eprint/8690
DOI: 10.6092/UNINA/FEDOA/8690

Collection description

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) are among the most lethal of human malignancies with s a very poor prognosis, with a <3% 5-years survival rate for untreated cancer. The actual therapies are limited to a little percentage of patients they are often diagnosed in advanced stages or even in metastatic conditions. In the last years, the idea of an “omics revolution” has given the basis to a new kind of therapies cancer, a molecular approach. In this work, we have focused our attention on mTOR pathway, its inhibitors and on their antiproliferative effects evaluating not only cell lines viability decrease after treatment with them, but also the molecular mechanism at basis of this phenomenon. In addition, our research project has investigated also somatostatin and dopamine receptor expression with the purpose to identify a molecular profile of this cancer, using four different cell lines and 23 Caucasian patients. So, stimulation of these receptors with the correspondent ligands has demostrated that their best therapeutical effect is observed with use of drugs with affinity for two different receptors, probably due to heterodimerization of somatostatin receptors. These data have been confirmed by different kinds of experiments (evaluating proliferation, hormone secretion and intracellular signalling) revealing an emergent aspect of HCC, its neuroendocrine fenotype. Our future purpose is to clarify better some molecular aspects that regulate heterodimerization and to define the intracellular pathways activated by these analogues. We, also are going to evaluate the effects of a potential combination between mTOR inhibitors and somatostatin analogues underlining a possible signalling interaction.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item